1-46510481-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_172225.2(DMBX1):āc.160A>Gā(p.Ile54Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_172225.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMBX1 | NM_172225.2 | c.160A>G | p.Ile54Val | missense_variant | 4/6 | ENST00000360032.4 | NP_757379.1 | |
DMBX1 | NM_001387776.1 | c.175A>G | p.Ile59Val | missense_variant | 3/5 | NP_001374705.1 | ||
DMBX1 | NM_147192.4 | c.175A>G | p.Ile59Val | missense_variant | 4/6 | NP_671725.1 | ||
DMBX1 | NM_001387775.1 | c.160A>G | p.Ile54Val | missense_variant | 3/5 | NP_001374704.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMBX1 | ENST00000360032.4 | c.160A>G | p.Ile54Val | missense_variant | 4/6 | 1 | NM_172225.2 | ENSP00000353132.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461476Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727048
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2024 | The c.175A>G (p.I59V) alteration is located in exon 2 (coding exon 2) of the DMBX1 gene. This alteration results from a A to G substitution at nucleotide position 175, causing the isoleucine (I) at amino acid position 59 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at